Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02355431
Title INCB039110 in Combination With Erlotinib in Non Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Activating Mutations
Recruitment Withdrawn
Gender both
Phase Phase II
Variant Requirements No
Sponsors Incyte Corporation
Indications

lung non-small cell carcinoma

Therapies

Erlotinib

Itacitinib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Ogden Utah United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field